Selected research
Market Structure
Global Methotrexate Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Methotrexate Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Methotrexate Sodium include HOSPIRA, Qualitest(DAVA Pharmaceuticals), Roxane Laboratories Inc., STADA Pharmaceuticals, Inc, Teva USA(Barr Laboratories) and Mylan Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Methotrexate Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Methotrexate Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Methotrexate Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Methotrexate Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.
Methotrexate Sodium Segment by Company
HOSPIRA
Qualitest(DAVA Pharmaceuticals)
Roxane Laboratories Inc.
STADA Pharmaceuticals, Inc
Teva USA(Barr Laboratories)
Mylan Pharmaceuticals Inc.
Methotrexate Sodium Segment by Type
Methotrexate Sodium Tablet
Methotrexate Sodium Solution
Methotrexate Sodium Segment by Application
Oral
Injection
Methotrexate Sodium Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Methotrexate Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methotrexate Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Methotrexate Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Methotrexate Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate Sodium Tablet
- Methotrexate Sodium Solution
Applications
- Oral
- Injection
Companies covered
- HOSPIRA
- Qualitest(DAVA Pharmaceuticals)
- Roxane Laboratories Inc.
- STADA Pharmaceuticals, Inc
- Teva USA(Barr Laboratories)
- Mylan Pharmaceuticals Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Methotrexate Sodium Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Methotrexate Sodium Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Methotrexate Sodium Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Methotrexate Sodium Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Methotrexate Sodium Market Dynamics
- 2.1 Methotrexate Sodium Industry Trends
- 2.2 Methotrexate Sodium Industry Drivers
- 2.3 Methotrexate Sodium Industry Opportunities and Challenges
- 2.4 Methotrexate Sodium Industry Restraints
3 Methotrexate Sodium Market by Manufacturers
- 3.1 Global Methotrexate Sodium Revenue by Manufacturers (2021-2026)
- 3.2 Global Methotrexate Sodium Sales by Manufacturers (2021-2026)
- 3.3 Global Methotrexate Sodium Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Methotrexate Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Methotrexate Sodium Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Methotrexate Sodium Manufacturers, Product Type & Application
- 3.7 Global Methotrexate Sodium Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Methotrexate Sodium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Methotrexate Sodium Players Market Share by Revenue in 2025
- 3.8.3 2025 Methotrexate Sodium Tier 1, Tier 2, and Tier 3
4 Methotrexate Sodium Market by Type
- 4.1 Methotrexate Sodium Type Introduction
- 4.1.1 Methotrexate Sodium Tablet
- 4.1.2 Methotrexate Sodium Solution
- 4.2 Global Methotrexate Sodium Sales by Type
- 4.2.1 Global Methotrexate Sodium Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Methotrexate Sodium Sales by Type (2021-2032)
- 4.2.3 Global Methotrexate Sodium Sales Market Share by Type (2021-2032)
- 4.3 Global Methotrexate Sodium Revenue by Type
- 4.3.1 Global Methotrexate Sodium Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Methotrexate Sodium Revenue by Type (2021-2032)
- 4.3.3 Global Methotrexate Sodium Revenue Market Share by Type (2021-2032)
5 Methotrexate Sodium Market by Application
- 5.1 Methotrexate Sodium Application Introduction
- 5.1.1 Oral
- 5.1.2 Injection
- 5.2 Global Methotrexate Sodium Sales by Application
- 5.2.1 Global Methotrexate Sodium Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Methotrexate Sodium Sales by Application (2021-2032)
- 5.2.3 Global Methotrexate Sodium Sales Market Share by Application (2021-2032)
- 5.3 Global Methotrexate Sodium Revenue by Application
- 5.3.1 Global Methotrexate Sodium Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Methotrexate Sodium Revenue by Application (2021-2032)
- 5.3.3 Global Methotrexate Sodium Revenue Market Share by Application (2021-2032)
6 Global Methotrexate Sodium Sales by Region
- 6.1 Global Methotrexate Sodium Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Methotrexate Sodium Sales by Region (2021-2032)
- 6.2.1 Global Methotrexate Sodium Sales by Region (2021-2026)
- 6.2.2 Global Methotrexate Sodium Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Methotrexate Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Methotrexate Sodium Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Methotrexate Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Methotrexate Sodium Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Methotrexate Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Methotrexate Sodium Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Methotrexate Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Methotrexate Sodium Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Methotrexate Sodium Revenue by Region
- 7.1 Global Methotrexate Sodium Revenue by Region
- 7.1.1 Global Methotrexate Sodium Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Methotrexate Sodium Revenue by Region (2021-2026)
- 7.1.3 Global Methotrexate Sodium Revenue by Region (2027-2032)
- 7.1.4 Global Methotrexate Sodium Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Methotrexate Sodium Revenue (2021-2032)
- 7.2.2 North America Methotrexate Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Methotrexate Sodium Revenue (2021-2032)
- 7.3.2 Europe Methotrexate Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Methotrexate Sodium Revenue (2021-2032)
- 7.4.2 Asia-Pacific Methotrexate Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Methotrexate Sodium Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Methotrexate Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 HOSPIRA
- 8.1.1 HOSPIRA Company Information
- 8.1.2 HOSPIRA Business Overview
- 8.1.3 HOSPIRA Methotrexate Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 HOSPIRA Methotrexate Sodium Product Portfolio
- 8.1.5 HOSPIRA Recent Developments
- 8.2 Qualitest(DAVA Pharmaceuticals)
- 8.2.1 Qualitest(DAVA Pharmaceuticals) Company Information
- 8.2.2 Qualitest(DAVA Pharmaceuticals) Business Overview
- 8.2.3 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Product Portfolio
- 8.2.5 Qualitest(DAVA Pharmaceuticals) Recent Developments
- 8.3 Roxane Laboratories Inc.
- 8.3.1 Roxane Laboratories Inc. Company Information
- 8.3.2 Roxane Laboratories Inc. Business Overview
- 8.3.3 Roxane Laboratories Inc. Methotrexate Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Roxane Laboratories Inc. Methotrexate Sodium Product Portfolio
- 8.3.5 Roxane Laboratories Inc. Recent Developments
- 8.4 STADA Pharmaceuticals, Inc
- 8.4.1 STADA Pharmaceuticals, Inc Company Information
- 8.4.2 STADA Pharmaceuticals, Inc Business Overview
- 8.4.3 STADA Pharmaceuticals, Inc Methotrexate Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 STADA Pharmaceuticals, Inc Methotrexate Sodium Product Portfolio
- 8.4.5 STADA Pharmaceuticals, Inc Recent Developments
- 8.5 Teva USA(Barr Laboratories)
- 8.5.1 Teva USA(Barr Laboratories) Company Information
- 8.5.2 Teva USA(Barr Laboratories) Business Overview
- 8.5.3 Teva USA(Barr Laboratories) Methotrexate Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva USA(Barr Laboratories) Methotrexate Sodium Product Portfolio
- 8.5.5 Teva USA(Barr Laboratories) Recent Developments
- 8.6 Mylan Pharmaceuticals Inc.
- 8.6.1 Mylan Pharmaceuticals Inc. Company Information
- 8.6.2 Mylan Pharmaceuticals Inc. Business Overview
- 8.6.3 Mylan Pharmaceuticals Inc. Methotrexate Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mylan Pharmaceuticals Inc. Methotrexate Sodium Product Portfolio
- 8.6.5 Mylan Pharmaceuticals Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Methotrexate Sodium Value Chain Analysis
- 9.1.1 Methotrexate Sodium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Methotrexate Sodium Production Mode & Process
- 9.2 Methotrexate Sodium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Methotrexate Sodium Distributors
- 9.2.3 Methotrexate Sodium Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst